dc.contributor.author | Yamada, Yasuhiro | |
dc.contributor.author | Ukimura, Osamu | |
dc.contributor.author | Kaneko, Masatomo | |
dc.contributor.author | Matsugasumi, Toru | |
dc.contributor.author | Fujihara, Atsuko | |
dc.contributor.author | Vourganti, Srinivas | |
dc.contributor.author | Marks, Leonard | |
dc.contributor.author | Sidana, Abhinav | |
dc.contributor.author | Klotz, Laurence | |
dc.contributor.author | Salomon, Georg | |
dc.contributor.author | de la Rosette, Jean J. M. C. H. | |
dc.date.accessioned | 2021-04-07T08:19:59Z | |
dc.date.available | 2021-04-07T08:19:59Z | |
dc.date.issued | 2021 | en_US |
dc.identifier.citation | Yamada, Y., Ukimura, O., Kaneko, M., Matsugasumi, T., Fujihara, A., Vourganti, S. ... de la Rosette, J. J. M. C. H. (2021). Moving away from systematic biopsies: Image-guided prostate biopsy (in-bore biopsy, cognitive fusion biopsy, MRUS fusion biopsy) -literature review. World Journal of Urology, 39(3), 677-686. https://dx.doi.org/10.1007/s00345-020-03366-x | en_US |
dc.identifier.issn | 0724-4983 | |
dc.identifier.issn | 1433-8726 | |
dc.identifier.uri | https://dx.doi.org/10.1007/s00345-020-03366-x | |
dc.identifier.uri | https://hdl.handle.net/20.500.12511/6709 | |
dc.description.abstract | Objective To compare the detection rate of clinically significant cancer (CSCa) by magnetic resonance imaging-targeted biopsy (MRI-TB) with that by standard systematic biopsy (SB) and to evaluate the role of MRI-TB as a replacement from SB in men at clinical risk of prostate cancer. Methods The non-systematic literature was searched for peer-reviewed English-language articles using PubMed, including the prospective paired studies, where the index test was MRI-TB and the comparator text was SB. Also the randomized clinical trials (RCTs) are included if one arm was MRI-TB and another arm was SB. Results Eighteen prospective studies used both MRI-TB and TRUS-SB, and eight RCT received one of the tests for prostate cancer detection. In most prospective trials to compare MRI-TB vs. SB, there was no significant difference in any cancer detection rate; however, MRI-TB detected more men with CSCa and fewer men with CISCa than SB. Conclusion MRI-TB is superior to SB in detection of CSCa. Since some significant cancer was detected by SB only, a combination of SB with the TB technique would avoid the underdiagnosis of CSCa. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Springer | en_US |
dc.rights | info:eu-repo/semantics/embargoedAccess | en_US |
dc.subject | Prostate Cancer | en_US |
dc.subject | Magnetic Resonance Imaging | en_US |
dc.subject | Target Biopsy | en_US |
dc.subject | Systematic Biopsy | en_US |
dc.title | Moving away from systematic biopsies: Image-guided prostate biopsy (in-bore biopsy, cognitive fusion biopsy, MRUS fusion biopsy) -literature review | en_US |
dc.type | review | en_US |
dc.relation.ispartof | World Journal of Urology | en_US |
dc.department | İstanbul Medipol Üniversitesi, Uluslararası Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Üroloji Ana Bilim Dalı | en_US |
dc.authorid | 0000-0002-6308-1763 | en_US |
dc.identifier.volume | 39 | en_US |
dc.identifier.issue | 3 | en_US |
dc.identifier.startpage | 677 | en_US |
dc.identifier.endpage | 686 | en_US |
dc.relation.publicationcategory | Diğer | en_US |
dc.identifier.doi | 10.1007/s00345-020-03366-x | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.identifier.scopusquality | Q1 | en_US |